 Home > Active Ingredient News > Immunology News > EHJCP: Cardiorenal risk comparison of celecoxib versus naproxen or ibuprofen for arthritis

EHJCP: Cardiorenal risk comparison of celecoxib versus naproxen or ibuprofen for arthritis

 Last Update: 2022-04-18
 Source: Internet
 Author: User

Tags

aromatase inhibitor drugs

ibuprofen 1 2

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Conclusion: Long-term use of non-steroidal anti-inflammatory drugs and arthritis patients have a lower incidence of cardiovascular and renal adverse reactions

Source: Obeid S, Libby P, Husni E, Cardiorenal Risk of Celecoxib compared to Naproxen, or Ibuprofen in Arthritis Patients: Insights from the PRECISION trial.

leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Isoprinosine CAS 36703-88-5

CAS No.: 36703-88-5

Pharmacy Grade

$88-98/KG FOB

Sirolimus CAS 53123-88-9

CAS No.: 53123-88-9

Pharmacy Grade

$88-98/KG FOB

Melatonine 99

CAS No.: 73-31-4

pharmaceutical grade

$100/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.